TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial. [electronic resource]
Producer: 20130619Description: 3284-8 p. digitalISSN:- 1528-0020
- Adult
- Aged
- Disease-Free Survival
- Female
- Follow-Up Studies
- Hematopoietic Stem Cell Transplantation -- methods
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- genetics
- Male
- Middle Aged
- Mutation
- Phosphoproteins -- genetics
- RNA Splicing Factors
- Receptor, Notch1 -- genetics
- Ribonucleoprotein, U2 Small Nuclear -- genetics
- Transplantation, Homologous -- methods
- Treatment Outcome
- Tumor Suppressor Protein p53 -- genetics
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.